Amiyaki Tei Co., Ltd. (TYO:2753)

Theseus Pharmaceuticals Revenue

Amiyaki Tei had revenue of 8.98B JPY in the quarter ending June 30, 2025, with 2.75% growth. This brings the company's revenue in the last twelve months to 35.57B, up 3.40% year-over-year. In the fiscal year ending March 31, 2025, Amiyaki Tei had annual revenue of 35.33B with 6.21% growth.

• Revenue (ttm): 35.57B
• Revenue Growth: +3.40%
• P/S Ratio: 0.88
• Revenue / Employee: 57.37M
• Employees: 620
• Market Cap: 31.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	35.33B	2.07B	6.21%
Mar 31, 2024	33.27B	4.73B	16.57%
Mar 31, 2023	28.54B	6.97B	32.34%
Mar 31, 2022	21.56B	-573.00M	-2.59%
Mar 31, 2021	22.14B	-9.74B	-30.55%